The levels of secretion of these inflammatory cytokines upon stimulation with anti-CD3 Ab were higher in the PBMCs of patients with RA compared to those from healthy subjects, and EC-18 effectively inhibited the production of IL-6 and IL-17 (Fig. 6A). Here, IL17A is linked to rheumatoid arthritis.